4basebio (LON:4BB) Insider Buys £5,850 in Stock

4basebio PLC (LON:4BB) insider Hansjörg Plaggemars acquired 1,000 shares of the stock in a transaction on Tuesday, February 10th. The shares were purchased at an average price of GBX 585 per share, for a total transaction of £5,850.

4basebio Trading Down 0.9%

Shares of 4basebio stock opened at GBX 569.75 on Friday. The company has a debt-to-equity ratio of 201.47, a quick ratio of 3.52 and a current ratio of 2.73. The firm has a 50-day moving average of GBX 600.82 and a 200-day moving average of GBX 733.82. 4basebio PLC has a 52-week low of GBX 520 and a 52-week high of GBX 1,220. The stock has a market cap of £88.23 million, a PE ratio of -5.76 and a beta of 1.09.

4basebio Company Profile

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients.

Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.